10x Genomics Pays $350 Million to Acquire ReadCoor, a Spatial-Omics Company
October 06, 2020 at 07:49 AM EDT
10x Genomics acquired ReadCoor, a Boston developer of In Situ technologies, for $350 million. ReadCoor's technology measures large numbers of molecules directly in tissue while preserving the precise location of the molecules in the tissue, the growing field of spatial-omics. 10x provides scientific researchers with products to analyze biologic systems at a single cell level. Decheng Capital of Shanghai and Silicon Valley led ReadCoor's $23 million Series A financing and $27 million Series B round. More details.... Stock Symbol: (NSDQ: TXG) Share this with colleagues: // //
